BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT06834347-completion@plaintrial.com
DTSTAMP:20261028T091317Z
DTSTART;VALUE=DATE:20271213
SUMMARY:A Phase 3 Study to Assess the Efficacy\, Safety\, and Tolerability 
 of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlle
 d Chronic Rhinosinusitis With Nasal Polyps — estimated completion date
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT06834347
URL:https://plaintrial.com/trial/NCT06834347
END:VEVENT
END:VCALENDAR